Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lipigon Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11221
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lipigon Pharmaceuticals AB (Lipigon Pharmaceuticals) is a lipid biology company that discovers and develops novel therapies for lipid disorders and other cardiometabolic risk factors. The company offers developing its products in various therapeutic areas such as cardiovascular and metabolic disorders. It discovers small molecule activators of lipoprotein lipase. Lipigon Pharmaceuticals’ lead product candidate is designed to significantly lower the elevated levels of TG, raise levels of HDL and improve other cardiometabolic risk factors. The company partners with other pharmaceutical companies to develop new projects. Lipigon Pharmaceuticals is headquartered in Umea, Sweden.

Lipigon Pharmaceuticals AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB – Key Competitors 13
Lipigon Pharmaceuticals AB – Key Employees 14
Lipigon Pharmaceuticals AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Apr 06, 2017: Lipigon Pharmaceuticals announces new appointed members of the board – Gisela Sitbon and Erik Lund 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Key Facts 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB, Key Competitors 13
Lipigon Pharmaceuticals AB, Key Employees 14

List of Figures
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • TaiwanJ Pharmaceuticals Co Ltd (6549):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiwanJ Pharmaceuticals Co Ltd (TaiwanJ) is a pharmaceutical company that develops and commercialize small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It develops TLR4, a transmembrane protein that provides key medi …
  • William Hill PLC:企業の戦略・SWOT・財務情報
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Federal Signal Corp (FSS):企業の財務・戦略的SWOT分析
    Federal Signal Corp (FSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fractyl Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fractyl Laboratories Inc (Fractyl) is a clinical-stage medical technology company that develops novel devices and procedures to overcome insulin resistance and restitute metabolic health. The company developed a device-based clinical platform to change the way of treating metabolic diseases. …
  • Corvel Corporation:企業の戦略・SWOT・財務分析
    Corvel Corporation - Strategy, SWOT and Corporate Finance Report Summary Corvel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chugach Electric Association, Inc.:企業の発電所・SWOT分析2018
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Depuy Synthes Companies:企業の戦略・SWOT・財務分析
    Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report Summary Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Universal Health Services Inc (UHS):製薬・医療:M&Aディール及び事業提携情報
    Summary Universal Health Services Inc (UHS) is a healthcare service provider the offers acute care and behavioral health services. The center provides services such as general and specialty surgery, internal medicine, obstetrics, oncology, diagnostic care, coronary care, emergency room care, radiolo …
  • UTS Biogastechnik GmbH:企業の戦略的SWOT分析
    UTS Biogastechnik GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food, herbal teas, skin-care and be …
  • The Scripps Research Institute:企業のM&A・事業提携・投資動向
    The Scripps Research Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Scripps Research Institute Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • The State Export-Import Bank of Ukraine:企業の戦略・SWOT・財務情報
    The State Export-Import Bank of Ukraine - Strategy, SWOT and Corporate Finance Report Summary The State Export-Import Bank of Ukraine - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆